Polyps are a notable cause of lower gastrointestinal bleeding. Currently, there is no reliable non-invasive biomarker to determine which children should undergo colonoscopy. This study aimed to evaluate fecal calprotectin (FCP) as a potential screening biomarker for colorectal polyps in children undergoing colonoscopy. This retrospective, single-center observational study analyzed children who underwent colonoscopy at the Children’s Hospital Zagreb between November 2013 and December 2023. The study included 672 children, 124 (18%) of whom were found to have one or more polyps, while the rest had normal colonoscopy findings. Children with polyps requiring polypectomy were compared to age-, sex-, and date-matched controls with normal colonoscopy. Receiver operating characteristic (ROC) analysis was performed to assess diagnostic accuracy and determine optimal cut-off values. FCP levels were significantly higher in children with polyps than in controls (719.2 ± 1065 vs. 253.5 ± 544 µg/g; p = 0.009). ROC curve analysis yielded an area under the curve (AUC) of 0.727 (95% CI 0.648–0.807). A cut-off value of 20.5 µg/g provided 90% sensitivity, while 741 µg/g achieved 90% specificity. Only 3% of children with polyps had FCP levels below the laboratory cut-off (< 20 µg/g). No correlation was found between FCP levels and polyp size, number, histological type, or location. Conclusions: Fecal calprotectin may serve as a useful screening tool for identifying children at risk for colonic polyps, potentially guiding decisions about colonoscopy. However, due to its non-specificity and the influence of various confounders, further prospective studies and standardized pediatric cut-offs are needed to validate its clinical utility.<Table Float="No" ID="Taba"> <tgroup cols="1"> <colspec align="left" colname="c1" colnum="1" /> <tbody> <row> <entry align="left" colname="c1"> What is Known: • Benign solitary colorectal polyps are an important cause of gastrointestinal bleeding in children. • Fecal calprotectin levels can be elevated in children with colorectal polyps. </entry> </row> <row> <entry align="left" colname="c1"> What is New: • In the largest pediatric study to date, normal fecal calprotectin levels were found to be rare among children with colorectal polyps; only 3% had FCP values below the laboratory cut-off.. • A fecal calprotectin cut-off of 20.5 µg/g achieved 90% sensitivity, while a cut-off of 741 µg/g corresponded to 90% specificity for detecting intestinal polyps in children.. </entry> </row> </tbody> </tgroup> </Table>

Can fecal calprotectin guide the need for colonoscopy in children with suspected polyps?

期刊论文
发表日期：

2025年10月7日

查看全文

Anita Kolobarić,
Ivana Trivić Mažuranić,
Paola Ruška,
Ana Močić Pavić,
Zrinjka Mišak,
Iva Hojsak

摘要

Polyps are a notable cause of lower gastrointestinal bleeding. Currently, there is no reliable non-invasive biomarker to determine which children should undergo colonoscopy. This study aimed to evaluate fecal calprotectin (FCP) as a potential screening biomarker for colorectal polyps in children undergoing colonoscopy. This retrospective, single-center observational study analyzed children who underwent colonoscopy at the Children’s Hospital Zagreb between November 2013 and December 2023. The study included 672 children, 124 (18%) of whom were found to have one or more polyps, while the rest had normal colonoscopy findings. Children with polyps requiring polypectomy were compared to age-, sex-, and date-matched controls with normal colonoscopy. Receiver operating characteristic (ROC) analysis was performed to assess diagnostic accuracy and determine optimal cut-off values. FCP levels were significantly higher in children with polyps than in controls (719.2 ± 1065 vs. 253.5 ± 544 µg/g; p = 0.009). ROC curve analysis yielded an area under the curve (AUC) of 0.727 (95% CI 0.648–0.807). A cut-off value of 20.5 µg/g provided 90% sensitivity, while 741 µg/g achieved 90% specificity. Only 3% of children with polyps had FCP levels below the laboratory cut-off (< 20 µg/g). No correlation was found between FCP levels and polyp size, number, histological type, or location. Conclusions: Fecal calprotectin may serve as a useful screening tool for identifying children at risk for colonic polyps, potentially guiding decisions about colonoscopy. However, due to its non-specificity and the influence of various confounders, further prospective studies and standardized pediatric cut-offs are needed to validate its clinical utility.

What is Known:

• Benign solitary colorectal polyps are an important cause of gastrointestinal bleeding in children.

• Fecal calprotectin levels can be elevated in children with colorectal polyps.

What is New:

• In the largest pediatric study to date, normal fecal calprotectin levels were found to be rare among children with colorectal polyps; only 3% had FCP values below the laboratory cut-off..

• A fecal calprotectin cut-off of 20.5 µg/g achieved 90% sensitivity, while a cut-off of 741 µg/g corresponded to 90% specificity for detecting intestinal polyps in children..